Laryngotracheobronchitis in hospitalized children: Clinical features;Laringotraqueobronquitis en niños hospitalizados: Características clínicas

Revista Chilena de Pediatria

Volumn 76, Issue 4, 2005, Pages 357-362

  Iñiguez Osmer, Fernando ^a   Vega Briceño, Luis E ^a   Pulgar B, Dahiana ^b   Díaz P, Carla ^b   Sánchez D, Ignacio ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Children; Croup; Epinephrine; Laryngotracheobronchitis; Steroids

Indexed keywords

ADRENALIN; ANTIBIOTIC AGENT; SALBUTAMOL; STEROID;

AGE DISTRIBUTION; ARTICLE; AUTUMN; CHILD; CLINICAL FEATURE; COUGHING; FEMALE; FEVER; HOSPITAL ADMISSION; HUMAN; IMMUNOFLUORESCENCE; LARYNGOTRACHEOBRONCHITIS; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OXYGEN THERAPY; PARAINFLUENZA VIRUS; PNEUMONIA; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SEX DIFFERENCE; STRIDOR; TRACHEITIS; VIRUS IDENTIFICATION;

EID: 27644454997     PISSN: 03704106     EISSN: 07176228     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Hammer J: Adquired upper airway obstruction. Pediatr Respir Rev 2004; 5: 25-33.
2. Fitzgerald D, Kilham H: Croup: assessment and evidence-based management. Med J Aust 2003; 179: 372-7.
3. Malhotra A, Krilov L: Viral Croup. Pediatr Rev 2001; 22: 5-12.
4. Bjornson C, Klassen T, Williamson J, et al: A randomized trial of a single dose of oral dexamethasone for mild croup. N Engl J Med 2004; 351: 1306-13.
5. Breese C: Respiratory syncytial virus and parainfluenza virus. N Engl J Med 2001; 344: 1917-28.
6. Nichols E, Horwitz I, Stagno S, Adlerstein L, Sepúlveda H: Laringitis Obstructiva. Rev Chil Pediatr 1968; 11: 941-9.
7. León A, Silva R, Figueroa A, et al: Laringitis aguda en pacientes hospitalizados. 1980-1986; Rev Pediatría (Santiago) 1989; 32: 10-7.
8. Rotta A, Wiryawan B: Respiratory emergencies in children. Respir Care 2003; 48: 248-58.
9. Laringitis Aguda Obstructiva. En: Norma técnica para el manejo de las enfermedades respiratorias del niño. Ministerio de Salud, 2002. Disponible en: www.med.uchile.cl/academica/departamentos/norte/pediatria/ publicaciones/boletin1.pdf
10. Knutson D, Aring A: Viral Croup. Am Fam Physician 2004; 69: 535-40.
11. Williams J, Harris P, Tollefson S, et al: Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. N Engl J Med 2004; 350: 443-50.
12. Crowe JE: Human metapneumovirus as a major cause of human respiratory tract disease. Pediatr Infect Dis J 2004; 23: 215-21.
13. Peltola V, Heikkinen T, Ruuskanen O: Clinical courses of croup caused by influenza and parainfluenza viruses. Pediatr Infect Dis J 2002; 21: 76-8.
14. Contreras I, Rosa G, Navarro M, et al: Estridor en el paciente pediátrico. Estudio descriptivo. Rev Chil Pediatr 2004; 75: 247-53.
15. Alvarez C, Holmgren L, Caussade S, Paz F, Jofre D, Sánchez I: Estridor de causa inhabitual en lactantes. Descripción de 3 casos. Rev Chil Pediatr 2002; 73: 152-8.
16. Valenzuela M, Hernández I, Alvarez P, Andrade M, Palominos G: Anillos vasculares y estridor. Rev Pediatría (Santiago) 1996; 39: 23-7.
17. Abara S: Obstrucción aguda de la vía aérea alta. Rev Chil Pediatr 1995; 66 Supl 2: 19-23.
18. Stoney P, Chakrabarti M: Experience of pulse oximetry in children with croup. J Laryngol Otol 1991; 105: 295-8.
19. Westley C, Cotton E, Brooks J: Nebulized racemic epinephrine by IPPB for the treatment of croup: a double-blind study. Am J Dis Child 1978; 132: 484-7.
20. Russel K, Wiebe N, Saenz A, et al: Glucocorticoides for croup. The Cochrane Database of Systematic Reviews 2003, Issue 4: CD001955.
21. Kristjansson S, Berg-Kelly K, Winso E: Inhalation of racemic adrenaline in the treatment of mild and moderately severe croup. Clinical symptom score and oxygen saturation measurements for evaluation of treatment effects. Acta Paediatr 1994; 83: 1156-60.
22. Waisman Y, Klein B, Boenning D, et al: Prospective randomized double-blind study comparing L-epinephrine and racemic epinephrine aerosols in the treatment of laryngo-tracheitis (croup). Pediatrics 1992; 89: 302-6.
23. Ausejo M, Saenz A, Pham B, et al: The effectiveness of glucocorticoids in treating croup: meta-analysis. BMJ 1999; 319: 595-600.
24. Geelhoed G, Macdonald W: Oral dexamethasone in the treatment of croup: 0,15 mg/k versus 0,3 mg/kg versus 0,6 mg/kg. Pediatr Pulmonol 1995; 20: 362-8.
25. Donaldson D, Poleski D, Knipple E, et al: Intramuscular versus oral dexamethasone for the treatment of moderate-to-severe croup: a randomized, double-blind trial. Acad Emerg Med 2003; 10: 16-21.
26. Leung A, Kellner J, Johnson D: Viral croup: a current perspective. J Pediatr Health Care 2004; 18: 297-301.
27. Geelhoed G, Macdonald W: Oral and inhaled steroids in croup: a randomized, placebo-controlled trial. Pediatr Pulmonol 1995; 20: 355-61.
28. Johnson D, Jacobson S, Edney P, Hadfield P. Mundy M, Schuh S: A comparison of nebulized budesonide, intramuscular dexamethasone, and placebo for moderately severe croup. N Engl J Med 1998; 339: 498-503.
29. Klassen T, Craig W, Moher D, et al: Nebulized budesonide and oral dexamethasone for treatment of croup: a randomized controlled trial. JAMA 1998; 279: 1629-32.
30. Griffin S, Ellis S, Fitzgerald-Barron A, Rose J, Egger M: Nebulised steroid in the treatment of croup: a systematic review of randomized controlled trials. Br J Gen Pract 2000; 50: 135-41.
31. Cetinkaya F, Tufekci BS, Kutluk G: A comparison of nebulized budesonide, and intramuscular, and oral dexamethasone for treatment of croup. Int J Pediatr Otorhinolaryngol 2004; 68: 453-6.